The Toxoplasma glucan phosphatase TgLaforin utilizes a distinct functional mechanism that can be exploited by therapeutic inhibitors is a research paper published in Journal of Biological Chemistry (2022). On theSindex it has a DataRank of 0. It has been cited 15 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Science Foundation
Grant: CHE 1808304
National Science Foundation
Grant: DBI 2018007
National Science Foundation
Grant: GRFP 1247392
National Science Foundation
Grant: MCB 1817414
National Institutes of Health
Grant: R01 CA069202
National Institutes of Health
Grant: R01 CA207288
National Institutes of Health
Grant: R21 AI150631
National Institutes of Health
Grant: R35 NS116824
NIAID NIH HHS
Grant: R01 AI145335
National Institutes of Health
Grant: 3R35NS116824-04S1
Brain Glycogen - Metabolism, Mechanisms, and Therapeutic Potential
National Science Foundation
Grant: 1817414
Defining glucan dikinase phosphorylation of starch from multiple kingdoms
National Institutes of Health
Grant: 2R01CA069202-12
Structure/Function of Protein Tyrosine Phosphatases
National Science Foundation
Grant: 1247392
Graduate Research Fellowships Program (GRFP)
National Institutes of Health
Grant: 5R01CA207288-02
Development of SHP2 inhibitors for targeted anti-cancer therapy
National Institutes of Health
Grant: 1R21AI150631-01A1
Role of amylopectin granules in chronic toxoplasmosis, an HIV-AIDS defining infection
National Science Foundation
Grant: 2018007
MRI: Acquisition of Hydrogen/Deuterium eXchange Mass Spectrometer
University of Kentucky
FWCI
2.93
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals